Newron Pharmaceuticals SpA
F:NP5
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Newron Pharmaceuticals SpA
F:NP5
|
IT |
|
C
|
Concentric AB
F:2DN
|
SE |
|
IT Link SA
F:IL8
|
FR |
|
H
|
Huadian Power International Corp Ltd
OTC:HPIFY
|
CN |
|
Artec Technologies AG
F:A6T
|
DE |
|
N
|
Nektar Therapeutics
F:ITH
|
US |
|
V
|
Vistry Group PLC
F:44B
|
UK |
|
XP Power Ltd
F:4XP
|
SG |
|
Vertu Motors PLC
F:V2N
|
UK |
|
C
|
China Everbright Ltd
F:EVI
|
HK |
|
B
|
Borussia Dortmund GmbH & Co KGaA
DUS:BVB
|
DE |
|
T
|
Team PLC
LSE:TEAM
|
JE |
|
B
|
Becket Invest PLC
LSE:TAB
|
UK |
|
Esprit Holdings Ltd
F:ESHA
|
HK |
|
S
|
Super Copper Corp
OTC:CUPPF
|
CA |
|
M
|
Melco International Development Ltd
OTC:MDEVF
|
HK |
|
K
|
Kopin Corp
XMUN:KOC
|
US |
|
S
|
Solargiga Energy Holdings Ltd
SWB:3FV
|
HK |
|
Euglena Co Ltd
F:8EG
|
JP |
|
CellaVision AB
F:C26
|
SE |
|
K
|
Kopin Corp
SWB:KOC
|
US |
|
Schaeffler AG
F:SHA0
|
DE |
|
S
|
Solaria Energia y Medio Ambiente SA
F:AOR
|
ES |
|
E
|
Encavis AG
DUS:ECV
|
DE |
Wall St Price Targets
NP5 Price Targets Summary
Newron Pharmaceuticals SpA
According to Wall Street analysts, the average 1-year price target for NP5 is 47.02 EUR with a low forecast of 26.3 EUR and a high forecast of 79.84 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NP5's stock price target?
Price Target
47.02
EUR
According to Wall Street analysts, the average 1-year price target for NP5 is 47.02 EUR with a low forecast of 26.3 EUR and a high forecast of 79.84 EUR.
What is the Revenue forecast for Newron Pharmaceuticals SpA?
Projected CAGR
40%
Over the last 14 years, the compound annual growth rate for Revenue has been 35%. The projected CAGR for the next 8 years is 40%.
What is the Gross Profit forecast for Newron Pharmaceuticals SpA?
Projected CAGR
41%
The compound annual growth rate for Gross Profit over the next 8 years is 41%.
